A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSD
NCT04714359
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
87
Enrollment
INDUSTRY
Sponsor class
Conditions
PTSD
Interventions
DRUG:
Midomafetamine HCl
Sponsor
Resilient Pharmaceuticals